BREAST CANCER AND ORAL CONTRACEPTIVES
- 23 November 1985
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 326 (8465), 1180-1181
- https://doi.org/10.1016/s0140-6736(85)92697-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Do regular ovulatory cycles increase breast cancer risk?Cancer, 1985
- ORAL CONTRACEPTIVES AND BREAST CANCERThe Lancet, 1983
- BREAST CANCER IN YOUNG WOMEN AND USE OF ORAL CONTRACEPTIVES: POSSIBLE MODIFYING EFFECT OF FORMULATION AND AGE AT USEThe Lancet, 1983
- The epidemiology of endometrial cancer in young womenBritish Journal of Cancer, 1983
- Antiestrogenic Effect of R5020, a Synthetic Progestin in Human Breast Cancer Cells in Culture*Journal of Clinical Endocrinology & Metabolism, 1983
- Oral Contraceptive Use and the Risk of Endometrial CancerJAMA, 1983
- Oral Contraceptive Use and the Risk of Ovarian CancerPublished by American Medical Association (AMA) ,1983
- Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breastBritish Journal of Cancer, 1981
- Recent and Past Use of Conjugated Estrogens in Relation to Adenocarcinoma of the EndometriumNew England Journal of Medicine, 1980
- "INCESSANT OVULATION" AND OVARIAN CANCERThe Lancet, 1979